Clinical trial
Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps…
NCT00092430 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00092430 |
|---|---|
| Title | Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) |
| Official title | A Comparison of the Safety, Tolerability, and Immunogenicity of a Refrigerator-Stable Measles, Mumps, Rubella, and Varicella Combination Vaccine V221 (Refrigerated) Versus V221 (Frozen) in Healthy Children |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Measles, Mumps, Rubella, Varicella |
| Intervention type | Biological |
| Interventions | V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks |
| Enrollment | 1,200 |
| Start date | Sep 26, 2002 |
| Primary completion | Jun 9, 2003 |
| Completion | Jun 9, 2003 |
| First posted | Sep 27, 2004 |
| Last update posted | Nov 15, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: